Comprehensive in vitro diagnostic test system for hepatocellular carcinoma risk assessment in patients with chronic liver disease. Integrates AFP-L3 and DCP biomarker testing for improved early detection.
Manufactured by
United States
FUJIFILM Healthcare Americas Corporation is an IVD manufacturer with over 90 years of investment in R&D resulting in world-class technologies. The company provides accurate and reliable point-of-care testing solutions. Recently joined by FUJIFILM Wako Diagnostics, a provider of clinical chemistry reagents and OEM partnerships, the company offers unique and reliable IVD assays and innovative instrumentation. Featured assays include Complement Activity (CH50), Non-Esterified Fatty Acid (NEFA), and HCC Biomarkers (AFP-L3 and DCP). Product offerings span OEM products, cholesterol testing, COVID testing, diabetes testing, electrolyte testing, glucose testing, hormones, veterinary products, reagents, and cancer markers.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Singlera GENOMICS (SHANGHAI) Ltd.
China · 5 relevant products
STRATEC/Diatron
Germany · 1 relevant product
HANGZHOU LAIHE BIOTECH CO.,LTD
China · 2 relevant products
i Med Laboratories Co., Ltd.
Thailand · 1 relevant product
Innovation Biotech (Beijing) Co., Ltd
China · 1 relevant product
Jiangsu Sunlant Bioengineering Co., Ltd.
China · 2 relevant products
BioChain (Beijing) Science & Technology. Inc.
China · 5 relevant products
Hipro Biotechnology Co., Ltd. CE CIBG
China · 1 relevant product
FLIM LABS SRL
Italy · 2 relevant products
Tascom Co., Ltd
South Korea · 1 relevant product
59 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →7 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 97 closest product alternatives
Singlera GENOMICS (SHANGHAI) Ltd. · China
A DNA methylation-based diagnostic test for early detection and risk assessment of hepatocellular carcinoma. Provides comprehensive screening capabilities for liver cancer malignancies.
STRATEC/Diatron · Germany
In-vitro diagnostic test for detecting tumor markers and cancer-related antigens in blood and other biological samples. The test aids in cancer screening, diagnosis, and treatment monitoring.
HANGZHOU LAIHE BIOTECH CO.,LTD · China
Rapid screening assays for AFP, CEA, PSA, and other key oncology markers enabling accessible, early-stage risk stratification in community health screening and specialist oncology settings. Offers quantitative fluorescence and semi-quantitative formats with low sample volume requirements of 50–100 µL serum/plasma. Multi-marker combo panels are available.
i Med Laboratories Co., Ltd. · Thailand
Diagnostic test for detection of cancer biomarkers in blood and body secretions. Identifies biomolecules produced and released by cancer cells for screening and monitoring purposes.
Innovation Biotech (Beijing) Co., Ltd · China
A diagnostic test kit for measuring alpha-fetoprotein (AFP) levels in serum samples. This test is used for screening and monitoring of hepatocellular carcinoma and other malignancies.
Jiangsu Sunlant Bioengineering Co., Ltd. · China
A microarray chemiluminescence protein chip detection test kit for simultaneous detection of 6 tumor markers specific to liver cancer. The kit enables high-throughput screening with superior specificity and sensitivity using the platform's sandwich immunoassay methodology.
BioChain (Beijing) Science & Technology. Inc. · China
Advanced early detection test for lung cancer screening utilizing molecular diagnostic technology. This in-development product represents the company's expansion into early detection for pulmonary malignancies. The test is designed for high-risk population screening and clinical intervention.
Hipro Biotechnology Co., Ltd. CE CIBG · China
Comprehensive diagnostic reagent kit for hepatic function assessment. Detects liver enzyme levels and markers of hepatic disease.
FLIM LABS SRL · Italy
A nanoparticle-enabled blood test utilizing biophotonic technology for early detection of pancreatic ductal adenocarcinoma. The test aims to identify pancreatic cancer at earlier stages, potentially improving patient survival rates significantly compared to conventional diagnostic methods.
Tascom Co., Ltd · South Korea
Point-of-care diagnostic system for evaluating liver function parameters. Suitable for hospitals, clinics, and pharmacies requiring rapid hepatic assessment.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A molecular diagnostic test utilizing DNA methylation technology for early detection of lung cancer. Enables risk assessment and early diagnosis of lung malignancies through liquid biopsy methodology.
HANGZHOU LAIHE BIOTECH CO.,LTD · China
Rapid screening diagnostic assays that detect key oncology markers including AFP, CEA, PSA, and FOB with low sample volume requirements. Designed to facilitate accessible early-stage risk stratification and are ideal for large-scale population health screening programs.
85 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products